From todays announcement regarding SubB2M cancer-specific probe.
"BARD1 had a post-Sienna acquisition cash position of approximately $10.4 million at 31 July 2020 that will be used to fund its ongoing research, development and commercial programs"
Wild
Ann: Appendix 4E and Annual Report to Shareholders, page-40
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.26M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2999 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 12299 | 3 |
View Market Depth
| Last trade - 07.00am 23/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |
Day chart unavailable